$1.79
At close: Dec 13, 4:00 PM EST
ATI Physical Therapy Inc Ordinary Shares - Class A Stock Guidance
ATIPOTC
ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) last issued guidance on November 4, 2024 for Q4 2024. The company guided revenue in the range of $182.00M - $192.00M for the period.
Compared to prior guidance, ATI Physical Therapy Inc Ordinary Shares - Class A raised its revenue forecast from a prior range of $180.00M - $190.00M.
ATI Physical Therapy Inc Ordinary Shares - Class A has issued 5 guidance updates between August 8, 2022 and November 4, 2024. During this period, the company raised its outlook 2 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Nov 4, 2024
Guidance Period
Q4 2024
Revenue Guidance Range
$182.00M - $192.00M
ATI Physical Therapy Inc Ordinary Shares - Class A Guidance History
Review all historical guidance issued by ATI Physical Therapy Inc Ordinary Shares - Class A, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP)?
The most recent guidance for ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) was reported on November 4, 2024 for Q4 2024. ATI Physical Therapy Inc Ordinary Shares - Class A forecasted revenue between $182.00M and $192.00M for the period.
What revenue range did ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) guide for?
ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) guided revenue in the range of $182.00M to $192.00M for Q4 2024.
Did ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) raise or lower guidance?
ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) raised its revenue guidance from a prior range of $180.00M - $190.00M to $182.00M - $192.00M for Q4 2024.
When did ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) last issue guidance?
ATI Physical Therapy Inc Ordinary Shares - Class A (ATIP) last issued guidance on November 4, 2024 for Q4 2024.
